XTANT MEDICAL HOLDINGS, INC.

Profile

Company Names

XTANT MEDICAL HOLDINGS, INC.
BACTERIN INTERNATIONAL HOLDINGS, INC.

Addresses

664 CRUISER LANE, BELGRADE, MT 59714

600 CRUISER LANE, BELGRADE, MT 59714

Phone Numbers

406-388-0480

 

Entity Type:

CORPORATION

Industry:

OTHER HEALTH CARE, BIOTECHNOLOGY

Year Incorporated:

2006

State Incorporated:

DELAWARE

Total Amount Raised:

$125,016,785.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2024-08-09 
$5,000,000.00 
$5,000,000.00 
$0.00 
Equity 
7
2023-07-06 
$15,000,000.00 
$15,000,000.00 
$0.00 
Equity 
6
2022-08-25 
$6,748,951.00 
$9,746,606.00 
$2,997,655.00 
Equity 
5
2021-02-24 
$20,000,000.00 
$36,250,002.00 
$16,250,002.00 
Equity 
4
2020-10-01 
$62,882,000.00 
$62,882,000.00 
$0.00 
Equity 
3
2013-06-10 
$4,850,001.00 
$4,850,001.00 
$0.00 
Equity 
2
2011-04-19 
$3,027,504.00 
$3,500,000.00 
$472,496.00 
Equity 
1
2010-06-30 
$7,508,329.00 
$17,250,000.00 
$9,741,671.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JOHN 
 
BAKEWELL 
DIRECTOR
JONN 
R. 
BEESON 
DIRECTOR
KEVIN 
BRANDT 
EXECUTIVE OFFICER
KEVIN 
D. 
BRANDT 
EXECUTIVE OFFICER
SEAN 
E. 
BROWNE 
EXECUTIVE OFFICER, DIRECTOR
KEN 
 
CALLIGAR 
DIRECTOR
GUY 
 
COOK 
DIRECTOR, EXECUTIVE OFFICER
GUY 
S. 
COOK 
EXECUTIVE OFFICER, DIRECTOR
MICHAEL 
 
EGGENBERG 
DIRECTOR
JOHN 
 
GANDALFO 
EXECUTIVE OFFICER
JOHN 
P. 
GANDOLFO 
EXECUTIVE OFFICER
MITCHELL 
 
GODFREY 
DIRECTOR
MITCHELL 
T. 
GODFREY 
EXECUTIVE OFFICER, DIRECTOR
DARREL 
 
HOLMES 
EXECUTIVE OFFICER
GREG 
 
JUDA 
EXECUTIVE OFFICER
MICHAEL 
 
LOPACH 
DIRECTOR
ROBERT 
 
MCNAMARA 
DIRECTOR
ROBERT 
E. 
MCNAMARA 
DIRECTOR
LORI 
D. 
MITCHELL-KELLER 
DIRECTOR
NICHOLAS 
 
NAVARRO 
EXECUTIVE OFFICER
SCOTT 
C. 
NEILS 
EXECUTIVE OFFICER
MATTHEW 
 
RIZZO 
DIRECTOR
MARK 
A. 
SCHALLENBERGER 
EXECUTIVE OFFICER
STAVROS 
G. 
VIZIRGIANAKIS 
DIRECTOR
JON 
 
WICKWIRE 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
OTHER HEALTH CARE 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2024-08-09 
D
OTHER HEALTH CARE 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2023-07-06 
D
OTHER HEALTH CARE 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2022-08-25 
D
OTHER HEALTH CARE 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2021-02-24 
D
OTHER HEALTH CARE 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2020-10-01 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2013-06-10 
D/A
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2011-04-19 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2011-04-19 
D
BIOTECHNOLOGY 
WHOLESALE-DURABLE GOODS, NEC [5099] 
DECLINE TO DISCLOSE 
Equity 
2010-06-30 
D
BIOTECHNOLOGY 
WHOLESALE-DURABLE GOODS, NEC [5099] 
DECLINE TO DISCLOSE 
Equity 
2010-06-30 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
CRAIG-HALLUM CAPITAL GROUP LLC
NONE
NONE
A.G.P./ALLIANCE GLOBAL PARTNERS
NONE
NONE
WILLIAM BLAIR + COMPANY, L.L.C.
NONE
NONE
MIDDLEBURY SECURITIES LLC
NONE
NONE
AXIOM CAPITAL MANAGEMENT, INC.